Gazyva

Sobre este medicamento

Originator: Gazyva by Genentech, Inc. · Manufacturer: Roche Pharma. Indication & Dosage: Gazyva (Obinutuzumab), is a prescription medicine used to treat of specific hematologic malignancies, including chronic lymphocytic leukemia and follicular lymphoma. As a monoclonal antibody, it targets the CD20 protein on B cells, thereby inhibiting the growth and survival of cancerous cells. Gazyva manufacturted by Roche Bangladesh Ltd. In Bangladesh. Obinutuzumab is given by injection into a vein by a health care professional. It is given as directed by patient’s doctor, usually once certain days each month. Side Effects: The most common side effects of Obinutuzumab are: Infusion-related reactions, Fatigue, Nausea, Fever, Cough, Diarrhea, Anemia, Infections (e.g., respiratory, urinary), Thrombocytopenia, Neutropenia. The above information comes from the Internet. Please consult with doctor for medical advice.

Esta información es solo de referencia y no constituye consejo médico. Consulte siempre a un profesional de la salud calificado.